Latest Regulatory Approvals News

Carnaby Resources reports robust drill results from its Trekelano Project, revealing a broadening copper-gold mineralised zone with high-grade intervals that suggest significant deposit growth potential.

Brightstar Resources has signed a pivotal Memorandum of Understanding with Paddington Gold, setting the stage for open pit mining at the Lady Shenton deposit starting early 2026. This agreement promises to significantly boost production and de-risk the Menzies Gold Project.

Xero Limited has announced a binding agreement to acquire Melio Limited for US$2.5 billion, backed by a fully underwritten A$1.85 billion equity raise. This strategic move aims to accelerate Xero’s US growth and more than double its FY25 revenue by FY28.

Xero Limited has agreed to acquire Melio Limited, a leading US SMB bill pay platform, for US$2.5 billion, marking a significant leap in its US growth strategy. The deal is backed by a substantial A$1.85 billion equity raise and aims to accelerate revenue and market presence by FY28.

Cyprium Metals has obtained crucial environmental and operational approvals to advance the phased redevelopment of its Nifty Copper Complex, setting the stage for a near-term production restart.

Radiopharm Theranostics has inked a clinical supply agreement with Cyclotek to support its Phase 1 trial of RAD 402, a novel radiotherapeutic targeting prostate cancer, set to commence in Australia in late 2025.

Rhythm Biosciences has regained NATA accreditation for its geneType laboratory, a key step toward commercialising its ColoSTAT® cancer risk test as an in-house diagnostic.

Capricorn Metals has extended its mining contract with MACA Ltd for Karlawinda and named MACA preferred contractor for Mt Gibson, locking in cost certainty and supporting production growth.

Amplia Therapeutics has secured US ethics approval to launch a Phase 2 trial combining its drug narmafotinib with FOLFIRINOX chemotherapy for advanced pancreatic cancer, marking a key step in its clinical development.

Garda Property Group has announced a quarterly distribution of AUD 0.018 per security, combining an ordinary and a special fully franked dividend, reflecting strong capital outcomes from FY24.

Microba Life Sciences announces a $12.5 million equity raise, including a strategic $8.3 million investment from Sonic Healthcare, aiming to fuel growth in the UK and achieve regional break-even by FY26.

Alligator Energy has raised A$17.25 million through a strongly supported placement to institutional investors, positioning the company to advance key development stages at its Samphire Uranium Project. The funds will underpin exploration, feasibility studies, and the upcoming Field Recovery Trial.